OSR Holdings

United States · Biotechnology Research

OSR Holdings (NASDAQ: OSRH) is a hub-and-spoke healthcare group building a diversified, high-impact portfolio of biotech and medtech subsidiaries. Listed on NASDAQ in 2025 and headquartered in Bellevue, WA, with operations across the US, South Korea, and Switzerland, we bring together cutting-edge science and responsible corporate stewardship to deliver meaningful outcomes for patients globally. Our current pipeline spans three high-growth areas: oral T-cell mediated immunotherapies for oncology, disease-modifying osteoarthritis drugs (DMOAD), and noninvasive continuous glucose monitoring (CGM) — a technology poised to transform diabetes care for millions worldwide. Guided by values of integrity, transparency, and collaboration, we centralize expertise and capital at the holding level so our subsidiaries can move with speed, rigor, and focus.